An estimated 50 million people around the world currently live with Alzheimer's disease or other dementias, dementia being a collective term for progressive syndromes that affect various expressions of cognitive function, such as memory and emotional expression. Alzheimer’s disease accounts for the majority of cases (50 to 70%, varying by country, based on Alzheimer’s Disease International and World Health Organization figures). For those directly affected and their loved ones, dementia can be a frightening experience, particularly as it is so poorly understood. However there remains little or no understanding of dementia in many, and the stigmatization and misinformation that surrounds dementia remains a global issue.
For 2022 World Alzheimer’s Day the theme Know Dementia, Know Alzheimer’s, organized annually by Alzheimer’s Disease International, focuses on diagnosis, the warning signs of dementia, with a special focus on post-diagnosis support. The aim of this international campaign is to highlight the importance of support for people living with dementia and families following a diagnosis.
Biomarkers in Alzheimer's Disease, 2016, Pages 3-23
Diagnosis and Treatment of Traumatic Brain Injury, 2022, Pages 27-38
Diseases of the Nervous System (Second Edition), 2021, Pages 81-107
Exercise to Prevent and Manage Chronic Disease Across the Lifespan, 2022, Pages 413-421
Genetics, Neurology, Behavior, and Diet in Dementia, The Neuroscience of Dementia, Volume 2, 2020, Pages 833-847
Human Caspases and Neuronal Apoptosis in Neurodegenerative Diseases, 2022, Pages 69-151
Nanomedical Drug Delivery for Neurodegenerative Diseases, 2022, Pages 223-242
Neurobiology of Brain Disorders (Second Edition), Biological Basis of Neurological and Psychiatric Disorders, 2022, Pages 313-336
Neurochemical Aspects of Alzheimer's Disease Risk Factors, Pathogenesis, Biomarkers, and Potential Treatment Strategies, 2017, Pages 47-91
Plant Extracts in Neurodegenerative Diseases, 2022, Pages 1-15